(ARKG) ARK Genomic Revolution - Performance -9.3% in 12m
Compare ARKG with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-56.65%
#43 in Group
Rel. Strength
34.24%
#5247 in Universe
Total Return 12m
-9.26%
#41 in Group
Total Return 5y
-46.43%
#45 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -
(?) Percentile in Group
12m Total Return: ARKG (-9.3%) vs SPY (13%)

5y Drawdown (Underwater) Chart

Top Performers in Health
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
PPH NASDAQ VanEck Pharmaceutical |
-1.77% | 0.96% | 60.6% | - | - | - | - | - |
IHE NYSE ARCA iShares U.S. |
-3.33% | 2.25% | 42.6% | - | - | - | - | - |
XLV NYSE ARCA Health Care Sector SPDR |
-4.67% | -1.23% | 51.2% | - | - | - | - | - |
IYH NYSE ARCA iShares U.S. Healthcare |
-4.83% | -2.71% | 44.6% | - | - | - | - | - |
VHT NYSE ARCA Vanguard Health Care |
-3.94% | -1.5% | 44.5% | - | - | - | - | - |
FHLC NYSE ARCA Fidelity MSCI Health Care |
-4.06% | -1.59% | 44.3% | - | - | - | - | - |
IHI NYSE ARCA iShares U.S. Medical |
-1.15% | 8.29% | 44.3% | - | - | - | - | - |
IXJ NYSE ARCA iShares Global Healthcare |
-2.91% | -1.36% | 39.6% | - | - | - | - | - |
Performance Comparison: ARKG vs SPY vs S&P 500
SPY (SPDR SP500 Trust ETF) is the Sector Benchmark for ARKG
Total Return (including Dividends) | ARKG | SPY | S&P 500 |
---|---|---|---|
1 Month | 7.67% | -0.45% | -0.45% |
3 Months | -18.14% | -6.29% | -6.29% |
12 Months | -9.26% | 13.04% | 13.04% |
5 Years | -46.43% | 111.82% | 111.82% |
Trend Score (consistency of price movement) | ARKG | SPY | S&P 500 |
1 Month | 79.5% | 47.5% | 47.5% |
3 Months | -84.6% | -87.3% | -87.3% |
12 Months | -35.6% | 54.3% | 54.3% |
5 Years | -89.9% | 84.2% | 84.2% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. SPY | vs. S&P 500 |
1 Month | #5 | 8.16% | 8.16% |
3 Month | #44 | -12.6% | -12.6% |
12 Month | #39 | -19.7% | -19.7% |
5 Years | #44 | -74.7% | -74.7% |
FAQs
Does ARKG ARK Genomic Revolution outperforms the market?
No,
over the last 12 months ARKG made -9.26%, while its related Sector, the SPDR SP500 Trust (SPY) made 13.04%.
Over the last 3 months ARKG made -18.14%, while SPY made -6.29%.
Over the last 3 months ARKG made -18.14%, while SPY made -6.29%.
Performance Comparison ARKG vs Indeces and Sectors
ARKG vs. Indices ARKG is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | -5.27% | 8.12% | -7.80% | -22.3% |
US NASDAQ 100 | QQQ | -6.19% | 5.77% | -8.51% | -24.2% |
US Dow Jones Industrial 30 | DIA | -4.73% | 10.5% | -7.04% | -18.5% |
German DAX 40 | DAX | -4.91% | 7.89% | -25.9% | -34.3% |
Shanghai Shenzhen CSI 300 | CSI 300 | -1.62% | 10.9% | -4.10% | -14.2% |
Hongkong Hang Seng | HSI | -4.87% | 9.19% | -8.33% | -22.2% |
India NIFTY 50 | INDA | -2.75% | 2.79% | -7.68% | -12.2% |
Brasil Bovespa | EWZ | -3.64% | 4.84% | -13.5% | -2.52% |
ARKG vs. Sectors ARKG is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | -5.42% | 8.27% | -13.8% | -32.7% |
Consumer Discretionary | XLY | -5.30% | 8.26% | -8.97% | -23.9% |
Consumer Staples | XLP | -3.21% | 8.49% | -11.9% | -20.2% |
Energy | XLE | -1.01% | 21.7% | -2.66% | 0.06% |
Financial | XLF | -4.16% | 9.68% | -14.7% | -31.9% |
Health Care | XLV | -2.57% | 12.3% | -2.64% | -8.03% |
Industrial | XLI | -5.59% | 7.37% | -8.84% | -20.0% |
Materials | XLB | -3.46% | 10.9% | 0.04% | -4.82% |
Real Estate | XLRE | -5.16% | 8.77% | -7.96% | -27.6% |
Technology | XLK | -6.83% | 5.24% | -4.85% | -19.7% |
Utilities | XLU | -3.99% | 7.57% | -12.2% | -30.1% |
Aerospace & Defense | XAR | -6.30% | 0.69% | -21.7% | -36.7% |
Biotech | XBI | -5.11% | 2.12% | 7.51% | -3.87% |
Homebuilder | XHB | -4.0% | 9.75% | 7.16% | -3.09% |
Retail | XRT | -4.03% | 8.83% | -1.84% | -7.75% |